Louisiana State Employees Retirement System acquired a new stake in shares of Chemed Corporation (NYSE:CHE - Free Report) during the first quarter, according to its most recent disclosure with the SEC. The fund acquired 4,100 shares of the company's stock, valued at approximately $1,549,000.
A number of other hedge funds also recently made changes to their positions in the stock. SG Americas Securities LLC grew its position in shares of Chemed by 773.5% during the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company's stock worth $11,324,000 after purchasing an additional 23,436 shares in the last quarter. Intech Investment Management LLC purchased a new position in Chemed in the 3rd quarter worth approximately $1,429,000. BNP Paribas Financial Markets boosted its stake in Chemed by 14.5% in the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company's stock worth $14,985,000 after purchasing an additional 4,430 shares during the period. Abacus FCF Advisors LLC bought a new position in Chemed in the 4th quarter worth approximately $5,935,000. Finally, C WorldWide Group Holding A S purchased a new stake in Chemed during the 4th quarter valued at approximately $2,189,000. 95.85% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several research firms have recently commented on CHE. Weiss Ratings raised shares of Chemed from a "sell (d+)" rating to a "hold (c-)" rating in a report on Wednesday, April 29th. Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a research note on Monday, June 8th. Zacks Research upgraded shares of Chemed from a "strong sell" rating to a "hold" rating in a report on Monday, April 27th. Finally, Royal Bank Of Canada boosted their price target on shares of Chemed from $422.00 to $436.00 and gave the stock a "sector perform" rating in a research note on Monday, April 27th. Two investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $501.50.
View Our Latest Analysis on Chemed
Chemed Trading Up 3.4%
Shares of CHE opened at $481.73 on Thursday. The company's fifty day moving average is $431.51 and its 200 day moving average is $425.98. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $486.58. The stock has a market capitalization of $6.39 billion, a PE ratio of 26.25, a P/E/G ratio of 1.75 and a beta of 0.52. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.
Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. During the same quarter last year, the business earned $5.63 earnings per share. Chemed's quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Sell-side analysts expect that Chemed Corporation will post 22.3 earnings per share for the current fiscal year.
Chemed Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were given a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed's dividend payout ratio (DPR) is currently 13.08%.
Insider Activity
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer directly owned 90,219 shares of the company's stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the company's stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 3.33% of the company's stock.
About Chemed
(
Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.